Cellply is a deep tech company with the ambition to develop analytical tools enabling fast end effective development of life-saving cancer cell therapies. Our solutions support biopharma companies and research institutes from discovery to R&D and quality control of advanced therapies. Our team features a unique combination of expertise in a diverse set of technology going from microfluidics to robotics, AI, biology and immunology.
Massimo Bocchi, PhD
Brought the company from idea to product developed, created the team, raised more than €10m between equity and grants, technology inventor, author of 7 patents, engineering and business background.
Roberto Guerrieri, PhD
Developed core technology, initial team and funding, serial entrepreneur (Silicon Biosystems acquired by Menarini), inventor of fingerprint sensor developed by Upek and acquired by Apple.
CEO and Co-founder
Head of Biology
Laboratory and Warehouse Specialist
Project Leader Analytical SW
Head of Control SW
Senior Hardware Engineer
Project Leader Analytical Methods
Project Leader Assay development
Junior Software Developer
Marketing and US Sales
GRANTS & PROJECTS
Development of an In-Vitro Diagnostic platform for functional precision medicine to predict the outcome of hematological cancer patients
COVID-19 - Regione ER
Sviluppo di un test prognostico sulla base del profilo immunitario dei pazienti con Coronavirus Disease 19 (COVID-19) ospedalizzati